(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 3.42% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Teleflex's revenue in 2025 is $3,047,324,000.On average, 12 Wall Street analysts forecast TFX's revenue for 2025 to be $141,767,918,045, with the lowest TFX revenue forecast at $140,661,011,474, and the highest TFX revenue forecast at $144,991,175,453. On average, 12 Wall Street analysts forecast TFX's revenue for 2026 to be $148,885,494,681, with the lowest TFX revenue forecast at $145,966,262,170, and the highest TFX revenue forecast at $165,241,728,169.
In 2027, TFX is forecast to generate $156,397,278,985 in revenue, with the lowest revenue forecast at $150,566,742,629 and the highest revenue forecast at $173,749,046,800.